Boston Scientific wins pre-market approval for an enhancement to its Precision Plus spinal cord stimulation system for treating chronic pain.
Boston Scientific Corp. (NYSE:BSX) launched two spinal cord stimulation lead splitters for use with its Precision Plus spinal cord stimulator system.
The new design enables multi-site placement of up to four spinal cord leads designed to deliver electrical pulses that mask back pain signals on their way to the brain.
Covidien’s 3-year study results showing positive outcomes for its Urgent PC Neuromodulation system in...
NEC Display Solutions wins 510(k) clearance for its 21-inch medical monitor systems.
J&J's former head of global cardiology makes the jump to CEO at Itamar Medical
Sunshine Heart raises $1.5 million of a hoped-for $25.5 million equity funding round.
J&J subsidiary Lifescan asks the courts to ban Shasta from using its logo, saying problems with...